Sr. Leader en Masse Exodus

Discussion in 'Bristol-Myers Squibb' started by anonymous, Nov 1, 2019 at 8:46 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Will the last person at BMS please turn out the lights behind you?

    Why are members of the Executive Leadership Team leaving Giovanni's team in droves, literally running for the exits? 200% turnover!
     

  2. anonymous

    anonymous Guest

    Murdo G. Susan S. Cutis F. Soon Anthony M. Al R. All went to Amgen in last 3 years to present. = A Hooper
     
  3. anonymous

    anonymous Guest

    All fine people for sure but when people leave, it offers opportunities for those like yourself to be promoted. Happy New Year and trust in yourself!
     
  4. anonymous

    anonymous Guest

    Promoted AKA cover your head so the brown stuff doesn't hit you.
     
  5. anonymous

    anonymous Guest

    Everyday you have a choice; be a positive force and an inspiration to your team and others or be negative and destroy your reputation. BMS is and will continue to be a great company. With TYK2 and a great pipeline, BMS will diversify from Eliquis and Opdivo. My advice, focus on the positives in life and make a difference each day. Leadership changes, that’s just a fact of life in corporate America. Deal with it.
     
  6. anonymous

    anonymous Guest

    If leadership constantly changes it was never leadership to begin with, no amount of positive thinking can make a great leader.
     
  7. anonymous

    anonymous Guest

    Amgen is like BMS-junior - same stupid processes and egotistical management who think they know everything just 2 or 3 years behind BMS. Couldn’t find their ass with both hands and taking forever to do anything. They probably pay the same consultants who just change the acronym for stupid processes by one letter. I’m seriously not kidding
     
  8. anonymous

    anonymous Guest

    This is a BMS board. Please leave.
     
  9. anonymous

    anonymous Guest

    The poster made comparisons between Amgen and BMS having comparable levels of incompetence......it was a valid post.
     
  10. anonymous

    anonymous Guest

    also Johanna Mercier...
     
  11. anonymous

    anonymous Guest

    Johanna went to Gilead, not Amgen. Big loss however.
     
  12. anonymous

    anonymous Guest

    BMaSs Core-Behaviors brainwashing worked spectacularly, comrade. now go get you victory gin ration, chop-chop.
     
  13. anonymous

    anonymous Guest

    BMS has always been fortunate enough to have great drugs. Pravachol Glucophage Monopril Avapro Plavix Abilify Eliquis. All the Oncology Drugs. Unfortunately leadership has never measured up. Dolan. Bancroft. Lamberto. Giovani. Kinda like BMS their private piggy bank but no solid leadership pedigree.
     
  14. anonymous

    anonymous Guest

    And Sam Moed continues to survive. He apparently has the photos- a former CEO with a sheep in the Italian countryside. If the pictures go public it would be embarrassment. Way to go Sam!!!
     
  15. anonymous

    anonymous Guest


    sorry, but our chance to make our TYK2 a winner left when we had to let the Otezla team go to Amgen - that group sold $2BILLION dollars of Otezla and that product is a dud. Imagine what they could have done with an oral product that works and has an even cleaner SE profile? Instead, we will launch within our "values" with a team focused on everything but sales performance.